GSK plc 13D and 13G filings for CureVac N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-13 6:05 pm Unchanged | 2025-08-07 | 13D | CureVac N.V. CVAC | GSK plc | 16,591,937 74.000% | 0 (Unchanged) | Filing |
| 2024-02-06 5:10 pm Purchase | 2023-12-31 | 13G | CureVac N.V. CVAC | GSK plc | 16,591,937 7.400% | 1,656,216 (+11.09%) | Filing |